MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathwayQing Ling, Jie Jin|EBioMedicine|2021Cited by 20
Author response for "Combined in‐vitro and in‐silico analyses of <scp>FGFR1</scp> variants: genotype‐phenotype study in idiopathic hypogonadotropic hypogonadism"Daoqi Wang, Jihong Liu, Jiahong Tan et al.|Unknown|2020Cited by 0